In the Know with Amol Sarva

Professor Matt Kaeberlein is an outspoken proponent of rapamycin, and pretty skeptical about virtually all the other interventions people talk most about. Here he lays out a pretty complete and persuasive model for why and how aging happens at all, and why some approaches are most likely to work.

A rare MD at the cutting edge of the longevity field, Dr. Barzilai heads the Institute for Longevity Research at Einstein. We cover his unique contributions, especially the currently buzzy topic of metformin, as well as his work on the genetic luck of centenarians.

One of the more incredible research programs in longevity is regeneration: rebuilding and replacing failing organs with lab-grown cells. Jean Herbert at Einstein is working on regenerating your brain.

This founder has been part of so many of the exciting longevity startups, investments, and discussions that you simply must understand the world the way he sees it before taking a view about life extension. In this episode, you will.

Longevity superstar alert. A deep dive with one of the most recognized and longest-serving visionaries of longevity world. After recording this episode, friends pointed out that I didn't cover big important parts of personal history that are covered here: https://en.wikipedia.org/wiki/Aubrey_de_Grey

The easy way to attack Parkinson's? A neuron-by-neuron model of the brain.

Cellular rejuvenation is in the house on this episode, and fundamental research on the processes far beneath the surface of your typical aging research. And a little peek into the billionaire-backed mega-project happening at Altos.